ISPOR Conference 2024
About
The conference focused on tackling burdensome healthcare conditions in Saudi Arabia by balancing improved access with spending efficiency.
Date & Time:
June 10th - June 11th
June 10th : 8:00 am - 4:00 pm
June 11th : 8:00 am - 5:00 pm
Objectives
- Understanding the socioeconomic impact of obesity and its implications for health policy and resource allocation.
- Gaining insights into contracting and market access strategies for orphan drugs within the healthcare system.
- Examining the current and future roles of artificial intelligence in enhancing healthcare delivery and outcomes.
- Analyzing the evolution of health economic evaluation in Saudi Arabia and its influence on current practices.
- Familiarizing with the new SFDA guidelines for health economics evaluations and their application in local healthcare assessments.
- Evaluating the use of Health Technology Assessment (HTA) methodologies for medical devices.
- Understanding the CHI drug formulary and the process of prioritizing indications for optimal resource utilization.
Agenda
Day 1:
Opening and Welcoming remarks
+
Dr. Hana Alabdulkarim
Session I: The Socioeconomic Burden of Obesity
+
Dr. Omar Almohammed
The Epidemiology of Obesity in Saudi Arabia
+
Dr.Majed Alkhalaf
Obesity Management in Saudi Arabia
+
Dr. Nisren Alfaris
Debate: Should We Reimburse Weight Loss Prescriptions?
+
Dr. Wali Yar, Dr. Majed Alkhalaf, Dr. Nisreen Alfaris
Session II: Contracting and Market Access Strategies for Orphan
Drugs
+
Dr. Tomaz Kluszczynski
Managed-Entry Agreement (MEA) : Case Studies
+
Prof. Dalia Dawoud
Systemic and pharmacoeconomic challenges with medicines reimbursement in rare diseases
+
Prof. Marcin Czech
Rare Health Conditions: Should Prioritize the Management of Rare Diseases in Saudi Arabia and What Can We Learn from Poland?
+
Prof. Maciej Neiwada
What needs to be done in terms of prioritizing the management of rare
conditions in Saudi Arabia
+
Dr Ahmed Bamaga
Session III: Claims Data for Economic Evaluation Studies and
Decision-making
+
Dr. Shadi Almoziny
The Value of Claims Data for Health Economics and Outcome Research: The Case in Saudi Arabia
+
Dr. Hussein Reka
Private Healthcare Industry: Roles and Responsibilities in Creating and Maintaining Big Health Data
+
Dr. WaIil Yar
The Role of Insurance Regulator in Improving Healthcare Spending Efficiency
+
Dr. Shadi Almoziny
Session IV: The Use of Artificial Intelligence in Healthcare
+
Dr. Abdulrahman Al-Alshaihk
Economic Implications of AI Use in Healthcare
+
Dr. Justus Wolff
Case Studies of AI Use in Healthcare
+
Dr. Justus Wolff
Day 2:
Session V: Economic evaluation: is it a must or a luxury?
+
Dr. Tomaz Kluszczynki
Health Economic Evaluation in the Kingdom Past and Present
+
Dr. Ahmed aljedai
Best Practices in Budget Impact Analyses in HTA
+
Dr. Nimer Alkhatib
The Shortcomings of Disease-Specific Economic Models Submitted to NICE for Technology Appraisal
+
Dr. Dalia Dawoud
Session VI: New Guidelines of SFDA Health Economics Evaluation: Open Panel
Discussion
+
Moderator: Prof. Bander Balkhi
Saudi FDA members
+
Session VII: HTA for Medical Devices
+
1- An overview of HTA for Medical Devices
2- Similarities and Differences in HTA between Medical Devices and Pharmaceuticals
3- Newly Published Italian guidelines of HTA for medical devices
4- HTA assessment for medical devices (The Italian prospective Case Studies) +
2- Similarities and Differences in HTA between Medical Devices and Pharmaceuticals
3- Newly Published Italian guidelines of HTA for medical devices
4- HTA assessment for medical devices (The Italian prospective Case Studies) +
Dr. Rosanna Tarricone
Session VIII: CHI Drug formulary: Prioritizing Indications
+
Dr Yazed Alruthia
An Overview of Value-based Drug Formulary
+
Dr Christiane Maskineh
An Overview of Value-based Drug Formulary
+
Dr Mirna Matni
Open Panel Discussion
+
All (CHI and CCHO, Ibrahim Aljaffali, Mohammed Aljumah)
Arab Network Meeting
+
Satellite symposium
+
Session IX: Poster Evaluation
+
Dr. Shatha Almuhaideeb
ISPOR students’ competition
+
Dr. Abdullah Althemery
Download the Agenda
Media
Videos:
President’s Message by Dr. Hana Alabdulkarim: Be Part of a Unique ISPOR Experience
ISPOR Saudi: Leading Pharmacoeconomics in Saudi Arabia – Prof. Yazed AlRuthia
Conference Agenda Overview – Dr. Mai AlSaqaaby
×
Images:
×
![Popup Image]()
